Komori
Nihon Flush (7820) · FactFull-year R&D expenses decreased

Research and development spending

First written in FY2018-Q2. . Latest entry: FY2026.

29entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2018-Q2 – FY20262017: 12018: 420182019: 420192020: 420202021: 420212022: 320222023: 420232024: 220242025: 220252026: 12026
Same theme, other companies
Decline in R&D expenditureA theme 57 companies write about · 53 as a headwind · 4 as a tailwind

48 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 57 companies compared. The sentences above are computed from all 57.
Full recordFilings, disclosures and news, newest first
  1. FY2026Full-year R&D expenses decreasedAnnual report

    「Research and development expenses by segment for the consolidated fiscal year under review were ¥7.161 million in Japan and ¥23.185 million in China, for a total of ¥30.346 million.」

    Full-year research and development expenses amounted to ¥30.346 million, down from ¥80.264 million in the prior fiscal year. Meanwhile, development of new products in response to customer requests is ongoing.
  2. FY2026-H1Interim R&D Expenses DeclinedAnnual report

    「The Group’s total research and development expenses for the six-month consolidated period were ¥28 million.」

    Research and development expenses for the interim period amounted to ¥28 million, down from ¥40 million in the prior-year period.
  3. FY2025Full-year R&D expenses decreasedAnnual report

    「Research and development expenses by segment for the consolidated fiscal year under review were ¥15.216 million in Japan and ¥65.048 million in China, for a total of ¥80.264 million.」

    Full-year research and development expenses amounted to ¥80.264 million, down from ¥124.747 million in the prior fiscal year. Development of new construction methods, entrance storage footwell lighting, 2,700-type storage-related products and other items is ongoing.
  4. FY2025-H1Interim R&D Expenses DeclinedAnnual report

    「The Group's research and development activities amounted to ¥40 million during the interim consolidated accounting period under review.」

    Research and development expenses for the interim period amounted to ¥40 million, down from ¥93 million in the prior-year period.
  5. FY2024-Q3Cumulative third-quarter R&D expenses increasedAnnual report

    「The Group's research and development activities amounted to ¥151 million during the cumulative third quarter of the consolidated fiscal year under review.」

    Research and development expenses for the cumulative third quarter amounted to ¥151 million, up from ¥91 million in the prior-year period and ¥93 million at the time of the previous quarterly report.
  6. FY2024-Q2Second-quarter R&D expenses increasedAnnual report

    「The Group's research and development activities amounted to ¥93 million during the cumulative second quarter of the consolidated fiscal year under review.」

    Research and development expenses for the cumulative second quarter amounted to ¥93 million, up from ¥57 million in the prior-year period.
  7. FY2024-Q1First-quarter R&D expenses increasedAnnual report

    「The Group's research and development activities amounted to ¥40 million during the cumulative first quarter of the consolidated fiscal year under review.」

    Research and development expenses for the first quarter amounted to ¥40 million, up from ¥27 million in the prior-year period.
  8. FY2023Full-year R&D expenses increasedAnnual report

    「Research and development expenses by segment for the consolidated fiscal year under review were ¥13.823 million in Japan and ¥110.924 million in China, for a total of ¥124.747 million.」

    Full-year research and development expenses amounted to ¥124.747 million, up from ¥77.695 million in the prior fiscal year. China accounted for ¥110.924 million and Japan for ¥13.823 million.
  9. FY2023-Q3Cumulative third-quarter R&D expenses increasedAnnual report

    「The Group's research and development activities amounted to ¥91 million during the cumulative third quarter of the consolidated fiscal year under review.」

    Research and development expenses for the cumulative third quarter amounted to ¥91 million, up from ¥63 million in the prior-year period.
  10. FY2023-Q2Increase in research and development expenses for the cumulative second quarterAnnual report

    「The amount of R&D activity for the group as a whole during the first six months of the current fiscal year was ¥57 million.」

    Research and development expenses for the cumulative second quarter amounted to ¥57 million, up from ¥40 million in the prior-year period.
  11. FY2023-Q1Update to first-quarter R&D expensesAnnual report

    「The Group's total research and development expenditure for the cumulative first quarter of the current consolidated fiscal year was ¥27 million.」

    Research and development expenses for the cumulative first quarter amounted to ¥27 million.
  12. FY2022-Q3Updated first nine months' research and development expensesAnnual report

    「The Group's research and development activities amounted to ¥63 million during the cumulative third quarter of the consolidated fiscal year under review.」

    Research and development expenses for the cumulative third quarter amounted to ¥63 million, up from ¥51 million at the time of the previous quarterly report.
  13. FY2022-Q2Updated first nine months' research and development expensesAnnual report

    「The Group's research and development activities amounted to ¥40 million during the cumulative second quarter of the consolidated fiscal year under review.」

    Research and development expenses for the cumulative second quarter amounted to ¥40 million.
  14. FY2022-Q1Update to first-quarter R&D expensesAnnual report

    「The Group's research and development activities amounted to ¥19 million during the cumulative first quarter of the consolidated fiscal year under review.」

    Research and development expenses for the cumulative first quarter amounted to ¥19 million.
  15. FY2021Full-year R&D expenses updatedAnnual report

    「Research and development expenses by segment for the consolidated fiscal year under review were ¥15.436 million in Japan and ¥62.259 million in China, for a total of ¥77.695 million.」

    Full-year research and development expenses amounted to ¥77.695 million, comprising ¥15.436 million in Japan and ¥62.259 million in China.
  16. FY2021-Q3Updated first nine months' research and development expensesAnnual report

    「The Group's research and development activities amounted to ¥51 million during the cumulative third quarter of the consolidated fiscal year under review.」

    Research and development expenses for the cumulative third quarter amounted to ¥51 million.
  17. FY2021-Q2Updated first nine months' research and development expensesAnnual report

    「The Group's research and development activities amounted to ¥33 million during the cumulative second quarter of the consolidated fiscal year under review.」

    Research and development expenses for the cumulative second quarter amounted to ¥33 million.
  18. FY2021-Q1First-quarter R&D expenses decreasedAnnual report

    「The Group's research and development activities amounted to ¥15 million during the cumulative first quarter of the consolidated fiscal year under review.」

    Research and development expenses for the cumulative first quarter amounted to ¥15 million, down from ¥18 million in the prior-year period.
  19. FY2020Full-year R&D expenses decreasedAnnual report

    「Research and development expenses by segment for the consolidated fiscal year under review were ¥13.258 million in Japan and ¥65.027 million in China, for a total of ¥78.286 million.」

    Full-year research and development expenses amounted to ¥78.286 million, down from ¥82.831 million in the prior fiscal year.
  20. FY2020-Q3Updated first nine months' research and development expensesAnnual report

    「The Group's research and development activities amounted to ¥54 million during the cumulative third quarter of the consolidated fiscal year under review.」

    Research and development expenses for the cumulative third quarter amounted to ¥54 million.
  21. FY2020-Q2Updated first nine months' research and development expensesAnnual report

    「The Group's research and development activities amounted to ¥37 million during the cumulative second quarter of the consolidated fiscal year under review.」

    Research and development expenses for the cumulative second quarter amounted to ¥37 million.
  22. FY2020-Q1Update to first-quarter R&D expensesAnnual report

    「The Group's total research and development expenditure for the cumulative first quarter of the current consolidated fiscal year was ¥18 million.」

    Research and development expenses for the cumulative first quarter amounted to ¥18 million.
  23. FY2019Full-year R&D expenses updatedAnnual report

    「Research and development expenses by segment for the consolidated fiscal year under review were ¥13.852 million in Japan and ¥68.978 million in China, for a total of ¥82.831 million.」

    Full-year research and development expenses amounted to ¥82.831 million, comprising ¥13.852 million in Japan and ¥68.978 million in China.
  24. FY2019-Q3Updated first nine months' research and development expensesAnnual report

    「The Group's research and development activities amounted to ¥54 million during the cumulative third quarter of the consolidated fiscal year under review.」

    Research and development expenses for the cumulative third quarter amounted to ¥54 million.
  25. FY2019-Q2Updated first nine months' research and development expensesAnnual report

    「The Group's research and development activities amounted to ¥35 million during the cumulative second quarter of the consolidated fiscal year under review.」

    Research and development expenses for the cumulative second quarter amounted to ¥35 million.
  26. FY2019-Q1Update to first-quarter R&D expensesAnnual report

    「The Group's research and development activities amounted to ¥17 million during the cumulative first quarter of the consolidated fiscal year under review.」

    Research and development expenses for the cumulative first quarter amounted to ¥17 million.
  27. FY2018R&D expenditure increasedAnnual report

    「Research and development expenses by segment for the consolidated fiscal year under review were ¥13.294 million in Japan and ¥42.940 million in China, for a total of ¥56.234 million.」

    Full-year research and development expenses amounted to ¥56.234 million, up from ¥9 million in the cumulative third quarter. Japan accounted for ¥13.294 million and China for ¥42.940 million.
  28. FY2018-Q3R&D expenditure increasedAnnual report

    「The Group's research and development activities amounted to ¥9 million during the cumulative third quarter of the consolidated fiscal year under review.」

    Research and development expenses for the cumulative third quarter amounted to ¥9 million, up from ¥6 million at the time of the previous quarterly report.
  29. FY2018-Q2First statedAnnual report

    「The Group's research and development activities amounted to ¥6 million during the cumulative second quarter of the consolidated fiscal year under review.」

    Research and development expenses for the cumulative second quarter amounted to ¥6 million for the Group as a whole.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Nihon Flush yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.